Latest News

biologics and money | Image credit: gopixa - stock.adobe.com
Study: More Biosimilar Competition Is Not Lowering Patient OOP Costs

March 29th 2024

Despite more biosimilars entering the market and generating significant savings for payers and health care systems, these savings are not resulting in lower out-of-pocket (OOP) costs for patients, according to a recent study.

syringes | Image credit: SOPONE - stock.adobe.com
Analyzing Safety of Switching From Originators to Biosimilars: A Meta-Analysis of 21 Trials

February 10th 2024

Blood test | Image Credit: luchschenF - stock.adobe.com
Rituximab Biosimilars Effective in Treating Immune Thrombocytopenia

January 15th 2024

blood stream | Image credit: olegganko - stock.adobe.com
Enoxaparin Biosimilar Shows Similar Efficacy to Originator in Preventing Postoperative Subclinical Thrombosis

December 16th 2023

drug development in lab | Image credit: Nakron - stock.adobe.com
IQVIA Highlights Opportunity to Cash In on Biosimilars for Biologics Losing Market Exclusivity

November 29th 2023

Video Interviews
canadian flag on a mountain

More News

© 2024 MJH Life Sciences

All rights reserved.